Skip to main content

Advertisement

Table 3 Macular pigment optical density (MPOD) response to placebo. See Table 2 for details.

From: Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

Subject/eye MPOD pre AU SD pre AU Rate of change in MPOD ± SE, mAU/day p Significance of rate of change
11/L 0.244 0.034 0.01 ± 0.43 0.99 No signif. change
11/R 0.246 0.055 -0.20 ± 0.26 0.46 No signif. change
12/L 0.570 0.043 -0.99 ± 0.23 0.0001 Signif. decrease
12/R 0.551 0.105 -0.10 ± 0.22 0.65 No signif. change
13/L 0.473 0.065 0.00 ± 0.30 0.99 No signif. change
13/R 0.397 0.077 0.66 ± 0.41 0.12 No signif. change
14/L 0.825 0.067 0.03 ± 0.94 0.98 No signif. change
14/R 0.922 0.186 0.36 ± 0.33 0.30 No signif. change
15/L 0.328 0.050 0.14 ± 0.22 0.53 No signif. change
15/R 0.334 0.058 -0.11 ± 0.24 0.66 No signif. change
16/L 0.492 0.048 -0.72 ± 0.16 <0.0001 Signif. decrease
16/R 0.527 0.022 -0.60 ± 0.18 0.0020 Signif. decrease
17/L 0.579 0.036 -0.64 ± 0.87 0.48 No signif. change
17/R 0.482 0.054 -0.32 ± 0.49 0.52 No signif. change
18/L 0.628 0.041 -0.28 ± 0.30 0.36 No signif. change
18/R 0.625 0.057 0.43 ± 0.28 0.13 No signif. change
19/L 0.739 0.143 -0.44 ± 0.33 0.19 No signif. change
19/R 0.693 0.076 -0.30 ± 0.36 0.41 No signif. change